The presence of autoimmune thyroid disease does not automatically preclude the use of GLP-1 receptor agonists like semaglutide
However, the effectiveness of these drugs in maintaining weight loss over time can vary among individuals, depending on adherence to treatment and lifestyle modifications
Today, patients in Milwaukee, Madison, and those looking for the best weight loss programs Chicago has to offer are often faced with a choice between two powerful options: Wegovy weight loss and Zepbound weight loss
Head-to-Head vs Semaglutide (Frias et al., 2021): Tirzepatide demonstrated superior glycemic control compared to semaglutide, supporting the dual-agonist advantage
Cunnington, C
Brunani A, Perna S, Soranna D, Rondanelli M, Zambon A, Bertoli S, et al